Hermetica Superfood Encyclopedia
The Short Answer
Khaya senegalensis contains limonoids (including gedunin and methylangolensate), polyphenols (catechin, chlorogenic acid, kaempferol), and oleic acid-rich seed oil that collectively mediate antimalarial, antioxidant, and antimicrobial actions. In vitro, its limonoids inhibit chloroquine-resistant Plasmodium falciparum at IC50 values of 1–10 μg/mL, while phenolic extracts achieve 66–86% DPPH radical scavenging at 100 μg/mL, supporting its role in West African antimalarial pharmacopeia.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordKhaya senegalensis benefits
African Mahogany — botanical close-up
Health Benefits
**Antimalarial Activity**
Bark and leaf limonoids, notably gedunin and methylangolensate, inhibit chloroquine-resistant Plasmodium falciparum in vitro at IC50 values of 1–10 μg/mL, suggesting interference with parasite redox homeostasis and protein synthesis pathways.
**Antioxidant Protection**
Seed coat phenolics (total soluble phenolics 2620 mg GAE/100 g DW) and δ-tocopherol (36 mg/100 g DW in kernel) confer potent free radical scavenging, with acetone and ethanol extracts achieving 66–86% DPPH inhibition at 100 μg/mL.
**Antimicrobial Effects**
Seed oil disrupts bacterial and fungal cell membranes, yielding minimum inhibitory concentrations of 0.5–1.8 mL against tested organisms and zones of inhibition of 8–20 mm against S. aureus, B. subtilis, and E. coli, with MBC values of 0.39–1.56 mg/mL against methicillin-resistant S. aureus.
**Anti-inflammatory Potential**
Tannins, saponins, and limonoids in bark and leaf extracts are traditionally used to manage inflammatory conditions and fever; these compound classes are well-recognized modulators of prostaglandin synthesis and NF-κB signaling in related Meliaceae species, though direct pathway confirmation for K. senegalensis remains limited.
**Antisickling Properties**
Stem bark extracts have been employed in West African ethnomedicine specifically for sickle cell disease management, consistent with reported abilities of phenolic-rich plant extracts to inhibit erythrocyte sickling by reducing oxidative stress and membrane rigidity.
**Cardiovascular-Supportive Nutritional Profile**
Seed kernels supply potassium (927.5 mg/100 g DW), magnesium (340.5 mg/100 g DW), and oleic acid (79% of fatty acid fraction), nutrients associated with blood pressure regulation, vascular tone, and anti-atherogenic lipid profiles.
**Wound Healing and Infection Control**
Traditional topical application of bark powders and seed oil utilizes the combined antimicrobial and antioxidant chemistry to accelerate wound closure and reduce microbial colonization, practices consistent with the documented inhibitory activity of the seed oil against common wound pathogens.
Origin & History
Natural habitat
Khaya senegalensis is a large deciduous tree native to the Sudano-Sahelian zone of West and Central Africa, spanning Senegal, Mali, Nigeria, Sudan, and Cameroon, where it thrives in semi-arid savanna woodlands and seasonally dry forests. The tree reaches heights of 20–30 meters and is cultivated both for its dense, durable timber—widely traded as African mahogany—and for its extensive ethnomedicinal value across Hausa, Yoruba, and other West African communities. Bark, seeds, leaves, and roots are harvested throughout the year, with bark decoctions and seed oil preparations being the most commonly traded medicinal products in regional markets.
“Khaya senegalensis holds a prominent position in the traditional medicine systems of the West African Sahel and Sudan savanna belt, where Hausa, Fulani, Wolof, and other communities have used its bark, leaves, seeds, and roots for centuries to treat malaria, febrile illnesses, skin infections, wound healing, and—distinctively—sickle cell disease management, a use that predates modern understanding of the condition by generations. The tree is culturally significant beyond medicine: its durable reddish-brown timber has been traded across sub-Saharan Africa and into European markets since at least the colonial era as a mahogany substitute, embedding it in both local economies and global timber trades. Traditional healers typically prepare bark decoctions by boiling fresh or dried material, sometimes combining it with other medicinal plants such as Azadirachta indica (neem) or Securidaca longepedunculata to potentiate antimalarial or antisickling effects. The tree is also referenced in ethnobotanical literature as a veterinary medicine, used by pastoralists to treat livestock infections and trypanosomiasis, further underscoring its broad perceived bioactivity across human and animal applications in the region.”Traditional Medicine
Scientific Research
The evidence base for Khaya senegalensis consists almost entirely of in vitro bioassays and phytochemical characterization studies, with no published randomized controlled trials or formal human pharmacokinetic studies identified as of 2024. Key in vitro findings include antimalarial IC50 values of 1–10 μg/mL for limonoid fractions against P. falciparum, antibacterial zones of inhibition of 8–20 mm and MBC values of 0.39–1.56 mg/mL against S. aureus and E. coli, and DPPH radical scavenging of 66–86% at 100 μg/mL for polyphenol-rich extracts; however, none of these studies report sample sizes, replication details, or blinding protocols consistent with rigorous experimental standards. Ethnobotanical surveys across Nigeria, Mali, and Sudan document consistent traditional use for malaria, sickle cell disease, and wound management, lending face validity to the in vitro findings, but translational relevance to clinical outcomes remains unestablished. The absence of animal pharmacodynamic and toxicology studies prior to human use represents a significant gap, meaning all current evidence must be classified as preliminary and hypothesis-generating rather than confirmatory.
Preparation & Dosage
Traditional preparation
**Bark Decoction (Traditional)**
20–50 g of dried stem bark boiled in 500 mL water for 20–30 minutes, filtered, and consumed as 1–2 cups daily for malaria or fever management; no standardized clinical dose established
**Seed Oil (Expressed/Cold-Pressed)**
8 mL in vitro, but no oral or topical dosing guidelines for humans have been formally validated
Applied topically for wound care and skin infections; antimicrobial MIC achieved at 0.5–1..
**Leaf Infusion (Traditional)**
Fresh or dried leaves steeped in hot water, used as antipyretic and anti-inflammatory tea; preparation volumes and frequencies vary by regional practice and are not standardized.
**Powdered Bark (Topical/Oral)**
Ground bark applied directly to wounds or mixed with water for oral ingestion in sickle cell and infection management; no validated dose range or standardization percentage exists.
**Standardized Extract (Research Grade Only)**
Acetone, ethanol, or methanol extracts used at 100 μg/mL in antioxidant assays; no commercial standardized extract with defined limonoid or phenolic content is currently marketed for human supplementation.
**Timing Notes**
Traditional preparations are typically administered 2–3 times daily during acute illness episodes; no pharmacokinetic data exist to guide optimal timing, half-life considerations, or food-effect interactions.
Nutritional Profile
Seed kernels are nutritionally dense, containing approximately 53% crude fat dominated by oleic acid (79% of fatty acids), making the oil monounsaturated and potentially cardioprotective; the seed coat contains 13% fat with a higher proportion of linoleic acid (8.23%) and catechins (99.14 mg/100 g DW). Total soluble phenolics are remarkably high, reaching 920 mg GAE/100 g DW in kernels and 2620 mg GAE/100 g DW in seed coats, with identified compounds including cinnamic acid (57.86 mg/100 g DW kernel), chlorogenic acid (26.79 mg/100 g DW coat), kaempferol (16.41 mg/100 g DW coat), and catechin (9.95 mg/100 g DW kernel). The vitamin E fraction is represented primarily by δ-tocopherol at 36 mg/100 g DW in kernel and 10 mg/100 g DW in coat, which is a less common but biologically active tocopherol isoform. Mineral content in kernels is notable: potassium (927.5 mg/100 g DW), magnesium (340.5 mg/100 g DW), and calcium (228.8 mg/100 g DW); bioavailability of these minerals may be reduced by the co-presence of tannins and phytates, which are known to complex divalent cations in the gastrointestinal tract.
How It Works
Mechanism of Action
The antimalarial activity of Khaya senegalensis is primarily attributed to its limonoid tetranortriterpenoids, particularly gedunin and methylangolensate, which are proposed to impair Plasmodium falciparum protein synthesis and disrupt parasite redox regulation, achieving IC50 values of 1–10 μg/mL against chloroquine-resistant strains in vitro; gedunin is also a known inhibitor of heat shock protein 90 (Hsp90), a chaperone critical to parasite survival. Seed and bark phenolics—including catechin (up to 99.14 mg/100 g DW in seed coat), chlorogenic acid, and kaempferol—donate hydrogen atoms to neutralize reactive oxygen species via DPPH and related radical-quenching pathways, with total antioxidant capacity reaching 2620 mg GAE/100 g DW in seed coat fractions. The antimicrobial mechanism of seed oil is membrane-disruptive: oleic acid (dominant fatty acid at 73–79% of total lipids) and associated phenolics intercalate into bacterial and fungal phospholipid bilayers, increasing permeability and causing intracellular leakage, as evidenced by MIC and MBC data against multiple pathogens. Anti-inflammatory actions are tentatively attributed to tannin- and saponin-mediated inhibition of arachidonic acid cascade enzymes and suppression of pro-inflammatory cytokine release, mechanisms well-characterized in related Meliaceae limonoids but not yet confirmed by targeted pathway studies specifically for K. senegalensis.
Clinical Evidence
No human clinical trials have been conducted on Khaya senegalensis extracts, seed oil, or isolated limonoids as of the available literature through 2024. The strongest preclinical signals are for antimalarial activity (limonoids, IC50 1–10 μg/mL vs. chloroquine-resistant P. falciparum) and broad-spectrum antimicrobial effects (seed oil MBC 0.39–1.56 mg/mL vs. MRSA), but these in vitro metrics cannot be directly extrapolated to human therapeutic doses without pharmacokinetic bridging studies. Traditional use in Hausa and broader West African pharmacopeia is well-documented ethnographically, providing a reasonable basis for hypothesis generation, but neither effect sizes, responder rates, nor safety margins have been established in controlled human cohorts. Confidence in clinical benefit is therefore low by evidence-based medicine standards, and the ingredient should be regarded as a candidate for further investigation rather than a validated therapeutic agent.
Safety & Interactions
Formal clinical safety data for Khaya senegalensis are absent; no human toxicology studies, maximum tolerated dose studies, or long-term safety trials have been published as of 2024. In vitro hemolytic activity has been reported for leaf extracts in combination preparations (HL50 approximately 1 hour 45 minutes to 2 hours 13 minutes), raising a precautionary concern about potential cytotoxicity at high concentrations, though this has not been quantified for seed or bark fractions alone. The tannin and saponin content of bark and seed coat fractions could plausibly cause gastrointestinal irritation, nausea, or reduced mineral absorption at high doses, consistent with the known pharmacology of these compound classes in other medicinal plants, but this has not been confirmed in controlled human observation. No drug interaction data are available; however, given that limonoids from related Meliaceae species (including azadirachtin from Azadirachta indica) can affect CYP450 enzyme activity, caution is warranted when combining K. senegalensis preparations with antimalarials (chloroquine, artemisinin), immunosuppressants, or narrow-therapeutic-index drugs; use during pregnancy and lactation is not recommended due to complete absence of safety data.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Khaya senegalensis (Desr.) A.Juss.African mahoganyCailcedrat (French West Africa)Oganwo (Yoruba)Dry zone mahoganyAfrican Mahogany (Khaya senegalensis)Madaci (Hausa)
Frequently Asked Questions
What is Khaya senegalensis used for medicinally?
Khaya senegalensis is primarily used in West African and Sudanese traditional medicine to treat malaria, febrile infections, sickle cell disease, skin wounds, and inflammation. The stem bark is most commonly prepared as a decoction for antimalarial use, while seed oil is applied topically for antimicrobial purposes; in vitro studies confirm limonoid fractions inhibit chloroquine-resistant Plasmodium falciparum at IC50 values of 1–10 μg/mL, though no human clinical trials have been completed.
Is African mahogany bark safe to consume?
No formal human safety or toxicology studies have been published for Khaya senegalensis bark or any of its preparations as of 2024. In vitro data suggest hemolytic potential at high concentrations, and the tannin and saponin content may cause gastrointestinal upset; the absence of clinical safety data means it should not be used during pregnancy, lactation, or alongside prescription antimalarials or CYP450-metabolized drugs without medical supervision.
What are the active compounds in Khaya senegalensis?
The primary bioactive compounds are limonoid tetranortriterpenoids (gedunin, methylangolensate) in bark and leaves, along with polyphenols including catechin (up to 99.14 mg/100 g DW in seed coat), chlorogenic acid, kaempferol, and cinnamic acid in seeds. Seeds also contain δ-tocopherol (36 mg/100 g DW kernel) and an oleic acid-rich oil (79% oleic acid in kernel), while tannins, saponins, alkaloids, and scopoletin are found across bark and leaf tissues.
How does Khaya senegalensis fight malaria?
The antimalarial activity is primarily attributed to limonoid compounds, particularly gedunin, which is a known inhibitor of heat shock protein 90 (Hsp90)—a molecular chaperone essential for Plasmodium falciparum survival. In vitro studies show limonoid-rich fractions from Khaya species inhibit chloroquine-resistant P. falciparum strains at IC50 values of 1–10 μg/mL, but these findings have not yet been translated into human pharmacokinetic or efficacy trials.
What are the nutritional benefits of Khaya senegalensis seeds?
Khaya senegalensis seed kernels are nutritionally rich, providing approximately 53% fat (dominated by heart-healthy oleic acid at 79%), high potassium (927.5 mg/100 g DW), magnesium (340.5 mg/100 g DW), calcium (228.8 mg/100 g DW), and exceptionally high total polyphenols (920 mg GAE/100 g DW in kernel, 2620 mg GAE/100 g DW in coat). The seed coat in particular offers dense antioxidant activity through catechin, chlorogenic acid, and δ-tocopherol, though co-present tannins may reduce mineral bioavailability via chelation in the gut.
Does Khaya senegalensis interact with antimalarial medications like chloroquine or artemisinin?
Khaya senegalensis contains limonoids that target similar parasite pathways as synthetic antimalarials, potentially creating additive effects or competitive interactions. Co-administration with prescription antimalarials should be supervised by a healthcare provider, as the combination may alter drug efficacy or increase the risk of adverse effects. Traditional use in malaria-endemic regions often involves Khaya alongside other botanicals rather than pharmaceutical antimalarials, but modern concurrent use requires medical guidance.
Is Khaya senegalensis safe for pregnant or breastfeeding women?
Safety data for Khaya senegalensis during pregnancy and lactation is limited, though traditional use in West African cultures suggests some historical application during reproductive periods. The presence of bioactive limonoids and phenolics warrants caution, as their effects on fetal development and breast milk composition have not been systematically studied. Pregnant or nursing women should consult a healthcare provider before supplementing with Khaya senegalensis products.
What does clinical research show about Khaya senegalensis effectiveness compared to synthetic antimalarials?
In vitro studies demonstrate that Khaya senegalensis limonoids inhibit chloroquine-resistant Plasmodium falciparum at IC50 values of 1–10 μg/mL, showing comparable potency to some synthetic agents in laboratory conditions. However, human clinical trials are limited, and most evidence comes from traditional use reports and laboratory studies rather than randomized controlled trials in malaria patients. Further clinical research is needed to establish bioavailability, optimal dosing, and real-world efficacy against active malaria infections.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w khaya-senegalensis-african-mahogany curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
